A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
PetMed Express, Inc. and subsidiaries, d/b/a PetMeds®, and as parent company of PetCareRx®, is a pioneer in pet healthcare, building a consumer-first digital platform in 1996 that transformed the way customers fulfill pet medications. Nearly thirty years later, as a leading nationwide direct-to-consumer pet health and wellness retailer, the Company markets and sells directly to consumers through its websites (Petmeds.com and PetCareRx.com), customer contact center (1-800-PetMeds), and mobile applications (iOS and Android). The Company provides access to top branded pharmaceuticals, generic medications, compounded prescription medications, pharmacy fulfillment, and personalized autoship capabilities. Our digital platform offers pet healthcare solutions for a broad range of chronic conditions, including those related to allergy, arthritis, anxiety, kidney, hyperthyroidism, and others for cat, dog, and horses.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 183M | 227M | 274M | 257M | 272M | 309M |
| Net Income | -65M | -6.3M | -7.5M | 5.1M | 19M | 31M |
| EPS | $-3.11 | $-0.30 | $-0.37 | $0.25 | $0.92 | $1.52 |
| Free Cash Flow | -23M | -395K | -194K | 23M | 17M | 38M |
| ROIC | -53.0% | -1.7% | -7.7% | 3.8% | 15.2% | 20.8% |
| Gross Margin | 30.2% | 30.5% | 30.9% | 27.6% | 28.3% | 29.1% |
| Debt/Equity | 0.00 | 0.75 | 0.76 | 0.52 | 0.46 | 0.33 |
| Dividends/Share | $0.00 | $0.00 | $0.60 | $1.20 | $1.20 | $1.12 |
| Operating Income | -59M | -1.5M | -8.2M | 6.1M | 24M | 38M |
| Operating Margin | -32.3% | -0.7% | -3.0% | 2.4% | 8.9% | 12.2% |
| ROE | -198.0% | -6.9% | -7.7% | 4.7% | 15.2% | 21.7% |
| Shares Outstanding | 21M | 21M | 20M | 21M | 20M | 20M |
PETMED EXPRESS INC passes 2 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average ROIC is 6.1% with a gross margin of 29.3%. At current prices, the estimated annualized return to fair value is -38.5%.
PETMED EXPRESS INC (PETS) has a 5-year average return on invested capital (ROIC) of 6.1%. This is below average and may indicate limited pricing power.
PETMED EXPRESS INC (PETS) has a market capitalization of $50M. It is classified as a small-cap stock.
Yes, PETMED EXPRESS INC (PETS) pays a dividend with a trailing twelve-month yield of 0.06%.
PETMED EXPRESS INC (PETS) operates in the Retail-Drug Stores And Proprietary Stores industry, within the Consumer Cyclical sector.
PETMED EXPRESS INC (PETS) reported annual revenue of $227 million in its most recent fiscal year, based on SEC EDGAR filings.
PETMED EXPRESS INC (PETS) has a net profit margin of -2.8%. The company is currently unprofitable.
PETMED EXPRESS INC (PETS) generated $-395 thousand in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
PETMED EXPRESS INC (PETS) has a debt-to-equity ratio of 0.75. This indicates moderate leverage.
PETMED EXPRESS INC (PETS) reported earnings per share (EPS) of $-0.30 in its most recent fiscal year.
PETMED EXPRESS INC (PETS) has a return on equity (ROE) of -6.9%. A negative ROE may indicate losses or negative equity.
PETMED EXPRESS INC (PETS) has a 5-year average gross margin of 29.3%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 16 years of financial data for PETMED EXPRESS INC (PETS), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
PETMED EXPRESS INC (PETS) has a book value per share of $4.07, based on its most recent annual SEC filing.